Speaker - Anthony Ford-Hutchinson

 Anthony  Ford-Hutchinson  Thumbnail


Dr. Ford-Hutchinson is Senior Vice President, Vaccines Research and Development Merck Research Laboratories. He has a 30 year record of success at Merck & Co., Inc. and was Senior Vice President and Site Head of Merck Frosst Canada during the development of Singulair® for the treatment of adult and pediatric asthma and allergic rhinitis and the discovery of selective COX-2 inhibitors for the treatment of osteoarthritis and pain. Before joining Merck he was a lecturer in the Chemical Pathology Department at Kings College Hospital Medical School in London doing leukotriene and prostaglandin research. Dr. Ford-Hutchinson obtained his Bachelor’s Degree in Biochemistry from the University of Birmingham, a Masters Degree in Molecular Enzymology from the University of Warwick, and a Ph.D. in Biochemistry from the University of London.

2 Programs

Sage Leadership Concludes Commons Congress 2013

04.20.13 | 00:30:13 min | 0 comments

Redefining How We Build Better Maps of Disease

04.21.12 | 00:58:01 min | 0 comments